Terms: = Pancreatic cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716
43 results:
1. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
[TBL] [Abstract] [Full Text] [Related]
2. PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis.
Moyo TK; Kishtagari A; Villaume MT; McMahon B; Mohan SR; Stopczynski T; Chen SC; Fan R; Huo Y; Moon H; Tang Y; Bejan CA; Childress M; Anderson I; Rawling K; Simons RM; Moncrief A; Caza R; Dugger L; Collins A; Dudley CV; Ferrell PB; Byrne M; Strickland SA; Ayers GD; Landman BA; Mason EF; Mesa RA; Palmer JM; Michaelis LC; Savona MR
Clin Cancer Res; 2023 Jul; 29(13):2375-2384. PubMed ID: 37036505
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysis.
Das S; Phillips S; Lee CL; Agarwal R; Bergsland E; Strosberg J; Chan JA; LaFerriere H; Ramirez RA; Berlin J; Dasari A
Eur J Cancer; 2023 Mar; 182():43-52. PubMed ID: 36738541
[TBL] [Abstract] [Full Text] [Related]
4. Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of pancreatic Adenocarcinoma.
Di Giorgio C; Lupia A; Marchianò S; Bordoni M; Bellini R; Massa C; Urbani G; Roselli R; Moraca F; Sepe V; Catalanotti B; Morretta E; Monti MC; Biagioli M; Distrutti E; Zampella A; Fiorucci S
Cells; 2022 Nov; 11(21):. PubMed ID: 36359879
[TBL] [Abstract] [Full Text] [Related]
5. Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
Akl L; Abd El-Hafeez AA; Ibrahim TM; Salem R; Marzouk HMM; El-Domany RA; Ghosh P; Eldehna WM; Abou-Seri SM
Eur J Med Chem; 2022 Dec; 243():114704. PubMed ID: 36095992
[TBL] [Abstract] [Full Text] [Related]
6. Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver cancer via Inhibition of STAT3.
Zhu X; Song G; Zhang S; Chen J; Hu X; Zhu H; Jia X; Li Z; Song W; Chen J; Jin C; Zhou M; Zhao Y; Xie H; Zheng S; Song P
Cancer Res; 2022 Nov; 82(21):3987-4000. PubMed ID: 36043912
[TBL] [Abstract] [Full Text] [Related]
7. IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer.
He Y; Luo W; Liu Y; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Ma YS; Yang H; Xu K; Zhang X; Xiao Y; Zhang P; Liang Y; Fu D; Yao F; Hu G
J Clin Invest; 2022 Oct; 132(20):. PubMed ID: 36006737
[TBL] [Abstract] [Full Text] [Related]
8. Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
Leung SS; Borg DJ; McCarthy DA; Boursalian TE; Cracraft J; Zhuang A; Fotheringham AK; Flemming N; Watkins T; Miles JJ; Groop PH; Scheijen JL; Schalkwijk CG; Steptoe RJ; Radford KJ; Knip M; Forbes JM
Diabetes; 2022 Sep; 71(9):1994-2008. PubMed ID: 35713929
[TBL] [Abstract] [Full Text] [Related]
9. Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study.
Zou S; Wang X; Chen H; Lin J; Wen C; Zhan Q; Chen H; Lu X; Deng X; Shen B
BMC Cancer; 2022 Jun; 22(1):649. PubMed ID: 35698045
[TBL] [Abstract] [Full Text] [Related]
10. Laparoscopic liver resection for colorectal liver metastases: retrospective analysis of prognostic factors and oncological outcomes in a single-center cohort.
Taillieu E; De Meyere C; Nuytens F; Vanneste G; Libbrecht L; Alaerts H; Parmentier I; Verslype C; D'Hondt M
Langenbecks Arch Surg; 2022 Sep; 407(6):2399-2414. PubMed ID: 35499586
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant RNA Splicing Is a Primary Link between Genetic Variation and pancreatic cancer Risk.
Tian J; Chen C; Rao M; Zhang M; Lu Z; Cai Y; Ying P; Li B; Wang H; Wang L; Li Y; Huang J; Fan L; Cai X; Ning C; Li Y; Zhang F; Wang W; Jiang Y; Liu Y; Wang M; Li H; Huang C; Yang Z; Chang J; Zhu Y; Yang X; Miao X
Cancer Res; 2022 Jun; 82(11):2084-2096. PubMed ID: 35363263
[TBL] [Abstract] [Full Text] [Related]
12. Lactylation-driven METTL3-mediated RNA m
Xiong J; He J; Zhu J; Pan J; Liao W; Ye H; Wang H; Song Y; Du Y; Cui B; Xue M; Zheng W; Kong X; Jiang K; Ding K; Lai L; Wang Q
Mol Cell; 2022 May; 82(9):1660-1677.e10. PubMed ID: 35320754
[TBL] [Abstract] [Full Text] [Related]
13. The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and jak1/Stat3 signaling.
Safari F; Shafiee Nejad N; Aghaei Nejad A
Med Oncol; 2022 Jan; 39(3):28. PubMed ID: 35059869
[TBL] [Abstract] [Full Text] [Related]
14. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via jak1/STAT5 pathway in tumor microenvironment.
Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
[TBL] [Abstract] [Full Text] [Related]
15. SHP1 Decreases Level of P-STAT3 (Ser727) and Inhibits Proliferation and Migration of pancreatic cancer Cells.
Zhang M; Hu X; Kang Y; Wang Z; Zhou W; Liu C; Yang X
J Environ Pathol Toxicol Oncol; 2021; 40(1):17-27. PubMed ID: 33639070
[TBL] [Abstract] [Full Text] [Related]
16. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.
Jung YY; Ko JH; Um JY; Chinnathambi A; Alharbi SA; Sethi G; Ahn KS
J Cell Physiol; 2021 Jul; 236(7):5253-5264. PubMed ID: 33368314
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
Grant RC; Denroche R; Jang GH; Nowak KM; Zhang A; Borgida A; Holter S; Topham JT; Wilson J; Dodd A; Jang R; Prince R; Karasinska JM; Schaeffer DF; Wang Y; Zogopoulos G; Berry S; Simeone D; Renouf DJ; Notta F; O'Kane G; Knox J; Fischer S; Gallinger S
Gut; 2021 Oct; 70(10):1894-1903. PubMed ID: 32933947
[TBL] [Abstract] [Full Text] [Related]
18. Oncogenic KRAS-Driven Metabolic Reprogramming in pancreatic cancer Cells Utilizes Cytokines from the Tumor Microenvironment.
Dey P; Li J; Zhang J; Chaurasiya S; Strom A; Wang H; Liao WT; Cavallaro F; Denz P; Bernard V; Yen EY; Genovese G; Gulhati P; Liu J; Chakravarti D; Deng P; Zhang T; Carbone F; Chang Q; Ying H; Shang X; Spring DJ; Ghosh B; Putluri N; Maitra A; Wang YA; DePinho RA
Cancer Discov; 2020 Apr; 10(4):608-625. PubMed ID: 32046984
[TBL] [Abstract] [Full Text] [Related]
19. PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer.
Liu Q; Guo L; Zhang S; Wang J; Lin X; Gao F
Mol Med; 2019 Sep; 25(1):44. PubMed ID: 31521106
[TBL] [Abstract] [Full Text] [Related]
20. microRNA-1225 inhibit apoptosis of pancreatic cancer cells via targeting jak1.
Zhong R; Li S; Fang K; Yang L; Wang L
Cell Cycle; 2019 May; 18(9):990-1000. PubMed ID: 30990343
[TBL] [Abstract] [Full Text] [Related]
[Next]
